Rights and permissions
About this article
Cite this article
Prazosin in BPH - the most cost-effective option. Pharmacoecon. Outcomes News 116, 9 (1997). https://doi.org/10.1007/BF03271701
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03271701